Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
LSB Industries
LXU
$824M
| $166K | ﹤0.01% |
18,983
+19
| +0.1% | +$150 |
|
2452
Anavex Life Sciences
AVXL
$231M
| $164K | ﹤0.01% |
32,213
+4
| +0% | +$23 |
|
2453
Stem
STEM
$44.3M
| $164K | ﹤0.01% |
3,744
+1
| +0% | +$56 |
|
2454
Allogene Therapeutics
ALLO
$625M
| $163K | ﹤0.01% |
36,498
| – | – |
|
2455
Applied Digital
APLD
$6.68B
| $162K | ﹤0.01% |
38,020
+69
| +0.2% | +$348 |
|
|
OLPX
2456
DELISTED
Olaplex Holdings
OLPX
| $162K | ﹤0.01% |
84,047
-433,236
| -84% | -$903K |
|
|
REFI
2457
Chicago Atlantic Real Estate Finance
REFI
$251M
| $160K | ﹤0.01% |
10,129
-1,247
| -11% | -$20K |
|
2458
GrafTech
EAF
$184M
| $160K | ﹤0.01% |
11,526
+34
| +0.3% | +$530 |
|
2459
Genie Energy
GNE
$370M
| $159K | ﹤0.01% |
10,568
+1
| +0% | +$19 |
|
|
AGTI
2460
DELISTED
Agiliti Inc
AGTI
| $158K | ﹤0.01% |
15,660
-3,057,860
| -99% | -$25.6M |
|
2461
Lyell Immunopharma
LYEL
$318M
| $155K | ﹤0.01% |
3,455
-1
| -0% | -$43 |
|
|
CMRC
2462
Commerce.com Inc Series 1
CMRC
$272M
| $154K | ﹤0.01% |
22,341
+13
| +0.1% | +$104 |
|
2463
James River Group Holdings
JRVR
$219M
| $153K | ﹤0.01% |
16,435
+2
| +0% | +$18 |
|
|
FFIC
2464
DELISTED
Flushing Financial
FFIC
| $150K | ﹤0.01% |
11,913
| – | – |
|
2465
Health Catalyst
HCAT
$160M
| $149K | ﹤0.01% |
19,777
+2
| +0% | +$18 |
|
|
EWCZ
2466
DELISTED
European Wax Center
EWCZ
| $148K | ﹤0.01% |
11,417
+1
| +0% | +$14 |
|
2467
AMC Global Media
AMCX
$450M
| $147K | ﹤0.01% |
12,123
+1
| +0% | +$15 |
|
2468
Replimune Group
REPL
$455M
| $147K | ﹤0.01% |
17,965
+2
| +0% | +$16 |
|
2469
Target Hospitality
TH
$1.43B
| $146K | ﹤0.01% |
13,466
+3
| +0% | +$28 |
|
2470
Aehr Test Systems
AEHR
$2.13B
| $146K | ﹤0.01% |
11,790
| – | – |
|
|
RAPT
2471
DELISTED
RAPT Therapeutics
RAPT
| $143K | ﹤0.01% |
2,000
| – | – |
|
2472
Alector
ALEC
$169M
| $142K | ﹤0.01% |
23,658
| – | – |
|
|
AFCG
2473
AFC Gamma
AFCG
$60.9M
| $141K | ﹤0.01% |
16,639
-2,005
| -11% | -$16.3K |
|
|
SRG
2474
Seritage Growth Properties
SRG
$138M
| $138K | ﹤0.01% |
14,283
+13
| +0.1% | +$122 |
|
|
CNSL
2475
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $137K | ﹤0.01% |
31,864
-1
| -0% | -$4 |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.